EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-center, prospective study evaluating safety and efficacy of a new endoscopic hemostat system in non-variceal upper gastrointestinal bleeding

Hardik Rughwani iD, Rajat Garg iD, Mohammed Faisal Habeeb, Nitin Jagtap, Zaheer Nabi, Pradev Inavolu, Shreevyshnavi Aachi, Mohan Ramchandani, Darisetty Santosh, Gauri Nayak, Sundeep Lakhtakia iD, Nageshwar Reddy

Endoscopy International Open · 29.07.2025 · 13 (CP)

DOI: 10.1055/a-2650-2692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 29.07.2025. Verfasst von Hardik Rughwani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Medical Gastroenterology, Asian Institute of Gastroenterology (AIG Hospitals), Hyderabad, India. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hemostasis, LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoscopic spray therapy has been shown to be effective and safe in managing upper gastrointestinal bleeding (UGIB). We aimed to evaluate safety and efficacy of the novel powder-based Resolv Endoscopic Hemostat System in managing UGIB. This was a single-center, prospective, single-arm study conducted from July 2022 to February 2023. It aimed to evaluate safety and efficacy of a novel plant-based polysaccharide, the Resolv Endoscopic Hemostat System, in achieving hemostasis in adult patients diagnosed with non-variceal upper gastrointestinal bleeding (UGIB) (Forest 1b/oozing bleeding). Participants in this study underwent endoscopy and received monotherapy treatment using the Resolv Endoscopic Hemostat System. Outcomes of interest were adverse events (AEs) related to the device within 72 hours and 30 days, immediate hemostasis, and rebleeding rates within 72 hours of the index procedure. A total of 59 patients (71.2% men) with mean age of 55.3 ± 14.2 years were included in the study. Causes of bleeding included post-polypectomy (n = 35, 59.3%), gastric ulcers (n = 13, 22%), malignant tumor (n = 4, 6.8%), post-biopsy-related needing hemostasis (n = 3, 5.1%), congestive gastropathy (n = 2, 3.4%), duodenal ulcer (n = 1, 1.7%), and portal hypertensive duodenopathy-related (n = 1, 1.7%). Resolv achieved a 100% success rate for immediate hemostasis with a 72-hour rebleeding rate of 5.1%. There were no AEs related to the device or mortality. Resolv Endoscopic Hemostat System is a safe and effective device for achieving immediate hemostasis in patients with non-variceal upper gastrointestinal bleeding. Future studies are required to examine its widespread adoption and applicability.

Schlagwörter

Stichwörter der Autor:innen

Endoscopy Small BowelEndoscopy Upper GI TractNon-variceal bleedingSmall intestinal bleedingUlcers (peptic and other)

Autor:innen und Institutionen

  • Dept. of Medical Gastroenterology, Asian Institute of Gastroenterology (AIG Hospitals), Hyderabad, India.
  • Dept. of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, United States.
  • Dept. of Medicine, NHS Ayrshire and Arran, Ayr, United Kingdom of Great Britain and Northern Ireland.
  • Dept. of Anaesthesia, Asian Institute of Gastroenterology (AIG Hospitals), Hyderabad, India.
  • Dept. of Medical Gastroenterology, TNMC & BYL Nair Ch. Hospital, Mumbai, India.

ORCID-Profile: Hardik Rughwani, Rajat Garg, Sundeep Lakhtakia

Förderung

  • Hemostasis, LLC

Zitieren

APA

Rughwani, H., Garg, R., Habeeb, M. F., Jagtap, N., Nabi, Z., Inavolu, P., Aachi, S., Ramchandani, M., Santosh, D., Nayak, G., Lakhtakia, S., & Reddy, N. (2025). Single-center, prospective study evaluating safety and efficacy of a new endoscopic hemostat system in non-variceal upper gastrointestinal bleeding. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2650-2692

Vancouver

Rughwani H, Garg R, Habeeb MF, Jagtap N, Nabi Z, Inavolu P, et al. Single-center, prospective study evaluating safety and efficacy of a new endoscopic hemostat system in non-variceal upper gastrointestinal bleeding. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2650-2692

BibTeX
@article{Rughwani2025,
  author = {Rughwani, Hardik and Garg, Rajat and Habeeb, Mohammed Faisal and Jagtap, Nitin and Nabi, Zaheer and Inavolu, Pradev and Aachi, Shreevyshnavi and Ramchandani, Mohan and Santosh, Darisetty and Nayak, Gauri and Lakhtakia, Sundeep and Reddy, Nageshwar},
  title = {Single-center, prospective study evaluating safety and efficacy of a new endoscopic hemostat system in non-variceal upper gastrointestinal bleeding},
  journal = {Endoscopy International Open},
  year = {2025},
  volume = {13},
  number = {CP},
  doi = {10.1055/a-2650-2692}
}
Kostenlos starten →